Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).

BACKGROUND:The World Health Organization recommends annual mass azithromycin administration in communities with at least 10% prevalence of trachomatous inflammation-follicular (TF) in children, with further treatment depending on reassessment after 3-5 years. However, the effect of stopping mass azi...

Full description

Bibliographic Details
Main Authors: Jeremy D Keenan, Zerihun Tadesse, Sintayehu Gebresillasie, Ayalew Shiferaw, Mulat Zerihun, Paul M Emerson, Kelly Callahan, Sun Y Cotter, Nicole E Stoller, Travis C Porco, Catherine E Oldenburg, Thomas M Lietman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-08-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC6091918?pdf=render

Internet

http://europepmc.org/articles/PMC6091918?pdf=render

Similar Items